Yang Bo, Liu Hong, Xu Qin-Wen, Sun Yi-Fan, Xu Sui, Zhang Hao, Tang Jian-Xia, Zhu Guo-Ding, Liu Yao-Bao, Cao Jun, Cheng Yang
Laboratory of Pathogen Infection and Immunity, Department of Public Health and Preventive Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, China.
Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Front Genet. 2021 Aug 5;12:688606. doi: 10.3389/fgene.2021.688606. eCollection 2021.
surface-related antigen (SRA) is located on the surfaces of gametocyte and merozoite and has the structural and functional characteristics of potential targets for multistage vaccine development. However, little information is available regarding the genetic polymorphism of . To determine the extent of genetic variation about by characterizing the sequence, 74 samples were collected from migrant workers who returned to China from 12 countries of Africa between 2015 and 2019. The full length of the gene was amplified and sequenced. The average pairwise nucleotide diversities (π) of gene was 0.00132, and the haplotype diversity () was 0.770. The average number of nucleotide differences () for was 3.049. The ratio of non-synonymous () to synonymous () substitutions across sites (/) was 1.365. Amino acid substitutions of SRA could be categorized into 35 unique amino acid variants. Neutrality tests showed that the polymorphism of PfSRA was maintained by positive diversifying selection, which indicated its role as a potential target of protective immune responses and a vaccine candidate. Overall, the ability of the N-terminal of PfSRA antibodies to evoke inhibition of merozoite invasion of erythrocytes and conserved amino acid at low genetic diversity suggest that the N-terminal of PfSRA could be evaluated as a vaccine candidate against infection.
表面相关抗原(SRA)位于配子体和裂殖子表面,具有作为多阶段疫苗开发潜在靶点的结构和功能特征。然而,关于其基因多态性的信息很少。为了通过表征该序列来确定其基因变异程度,从2015年至2019年期间从非洲12个国家返回中国的农民工中收集了74个样本。对该基因的全长进行了扩增和测序。该基因的平均成对核苷酸多样性(π)为0.00132,单倍型多样性(Hd)为0.770。该基因的平均核苷酸差异数(k)为3.049。跨位点非同义(dN)与同义(dS)替换的比率(dN/dS)为1.365。恶性疟原虫SRA的氨基酸替换可分为35种独特的氨基酸变体。中性检验表明,恶性疟原虫SRA的多态性是由正向多样化选择维持的,这表明其作为保护性免疫反应潜在靶点和疫苗候选物的作用。总体而言,恶性疟原虫SRA抗体N端诱发抑制裂殖子侵入红细胞的能力以及低遗传多样性下的保守氨基酸表明,恶性疟原虫SRA的N端可作为抗疟感染疫苗候选物进行评估。